Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04876313
Title An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) (NURE-Combo)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors IRCCS San Raffaele
Indications

bladder urothelial carcinoma

Therapies

Nab-paclitaxel + Nivolumab

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.